Sven Marcel Stefan

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 32

Top Venues

Journal of medicinal chemistry

Neural regeneration research

Scientific data

International journal of molecular sciences

University of Oslo

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Oslo

Norway

Postdoctoral Research Associate :: Translational Neurodegeneration Research and Neuropathology Lab

University of Sydney

Australia

Postdoctoral Research Associate :: Molecular Pharmacology and Pathology Program

University of Bonn

Germany

Postdoctoral Research Associate :: Pharmaceutical Chemistry II

University of Bonn

Germany

Doctoral Candidate :: Pharmaceutical Chemistry II

University of Bonn

Germany

Master's Student :: Pharmaceutical Biology

Publications

Muhammad Rafehi, Marius Möller, Wouroud Ismail Al-Khalil, Sven Marcel Stefan
Medicinal Polypharmacology in the Clinic - Translating the Polypharmacolome into Therapeutic Benefit. Pharmaceutical research 41 (3) (2024)
Muhammad Rafehi, Marius Möller, Wouroud Ismail Al-Khalil, Sven Marcel Stefan
Medicinal Polypharmacology in the Clinic - Translating the Polypharmacolome into Therapeutic Benefit. Pharmaceutical research 41 (3) (2024)
Jörg Haupenthal, Muhammad Rafehi, Andreas Martin Kany, Anne Lespine, Katja Stefan, Anna Katharina Herta Hirsch, Sven Marcel Stefan
Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy-coupling factor transporters (ECFTs). Archiv der Pharmazie 357 (9) (2024)
Katja Stefan, Vigneshwaran Namasivayam, Sven Marcel Stefan
Computer-aided pattern scoring - A multitarget dataset-driven workflow to predict ligands of orphan targets. Scientific data 11 (1) (2024)
Katja Stefan, Vigneshwaran Namasivayam, Sven Marcel Stefan
Computer-aided pattern scoring - A multitarget dataset-driven workflow to predict ligands of orphan targets. Scientific data 11 (1) (2024)
Jörg Haupenthal, Muhammad Rafehi, Andreas Martin Kany, Anne Lespine, Katja Stefan, Anna Katharina Herta Hirsch, Sven Marcel Stefan
Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy-coupling factor transporters (ECFTs). Archiv der Pharmazie (2024)
Muhammad Rafehi, Marius Möller, Wouroud Ismail Al-Khalil, Sven Marcel Stefan
Medicinal Polypharmacology in the Clinic - Translating the Polypharmacolome into Therapeutic Benefit. Pharmaceutical research (2024)
Muhammad Rafehi, Marius Möller, Wouroud Ismail Al-Khalil, Sven Marcel Stefan
Medicinal Polypharmacology in the Clinic - Translating the Polypharmacolome into Therapeutic Benefit. Pharmaceutical research 41 (3) (2024)
Katja Stefan, Vigneshwaran Namasivayam, Sven Marcel Stefan
Computer-aided pattern scoring - A multitarget dataset-driven workflow to predict ligands of orphan targets. Scientific data 11 (1) (2024)
Sven Marcel Stefan, Muhammad Rafehi
The big data challenge - and how polypharmacology supports the translation from pre-clinical research into clinical use against neurodegenerative diseases and beyond. Neural regeneration research 19 (8) (2023)
Luisa Möhle, Katja Stefan, Pablo Bascuñana, Mirjam Brackhan, Thomas Brüning, Ivan Eiriz, Ahmed El Menuawy, Sylvie van Genderen, Irene Santos-García, Anna Maria Górska, María Villa, Jingyun Wu, Sven Marcel Stefan, Jens Pahnke
ABC Transporter C1 Prevents Dimethyl Fumarate from Targeting Alzheimer's Disease. Biology 12 (7) (2023)
Sven Marcel Stefan, Muhammad Rafehi
The big data challenge - and how polypharmacology supports the translation from pre-clinical research into clinical use against neurodegenerative diseases and beyond. Neural regeneration research 19 (8) (2023)
Sven Marcel Stefan, Muhammad Rafehi
The big data challenge - and how polypharmacology supports the translation from pre-clinical research into clinical use against neurodegenerative diseases and beyond. Neural regeneration research 19 (8) (2023)
Sven Marcel Stefan, Muhammad Rafehi
Medicinal polypharmacology: Exploration and exploitation of the polypharmacolome in modern drug development. Drug development research (2023)
Sven Marcel Stefan, Muhammad Rafehi
The big data challenge - and how polypharmacology supports the translation from pre-clinical research into clinical use against neurodegenerative diseases and beyond. Neural regeneration research 19 (8) (2023)
Jingyun Wu, Luisa Möhle, Thomas Brüning, Iván Eiriz, Muhammad Rafehi, Katja Stefan, Sven Marcel Stefan, Jens Pahnke
A Novel Huntington's Disease Assessment Platform to Support Future Drug Discovery and Development. International journal of molecular sciences 23 (23) (2022)
Jingyun Wu, Luisa Möhle, Thomas Brüning, Iván Eiriz, Muhammad Rafehi, Katja Stefan, Sven Marcel Stefan, Jens Pahnke
A Novel Huntington's Disease Assessment Platform to Support Future Drug Discovery and Development. International journal of molecular sciences 23 (23) (2022)
Sachin Puri, Katja Stefan, Sharuk L Khan, Jens Pahnke, Sven Marcel Stefan, Kapil Juvale
Indole Derivatives as New Structural Class of Potent and Antiproliferative Inhibitors of Monocarboxylate Transporter 1 (MCT1; SLC16A1). Journal of medicinal chemistry (2022)
Jingyun Wu, Luisa Möhle, Thomas Brüning, Iván Eiriz, Muhammad Rafehi, Katja Stefan, Sven Marcel Stefan, Jens Pahnke
A Novel Huntington's Disease Assessment Platform to Support Future Drug Discovery and Development. International journal of molecular sciences 23 (23) (2022)
Sachin Puri, Katja Stefan, Sharuk L Khan, Jens Pahnke, Sven Marcel Stefan, Kapil Juvale
Indole Derivatives as New Structural Class of Potent and Antiproliferative Inhibitors of Monocarboxylate Transporter 1 (MCT1; SLC16A1). Journal of medicinal chemistry (2022)
Sachin Puri, Katja Stefan, Sharuk L Khan, Jens Pahnke, Sven Marcel Stefan, Kapil Juvale
Indole Derivatives as New Structural Class of Potent and Antiproliferative Inhibitors of Monocarboxylate Transporter 1 (MCT1; SLC16A1). Journal of medicinal chemistry 66 (1) (2022)
Sachin Puri, Katja Stefan, Sharuk L Khan, Jens Pahnke, Sven Marcel Stefan, Kapil Juvale
Indole Derivatives as New Structural Class of Potent and Antiproliferative Inhibitors of Monocarboxylate Transporter 1 (MCT1; SLC16A1). Journal of medicinal chemistry 66 (1) (2022)
Sachin Puri, Katja Stefan, Sharuk L Khan, Jens Pahnke, Sven Marcel Stefan, Kapil Juvale
Indole Derivatives as New Structural Class of Potent and Antiproliferative Inhibitors of Monocarboxylate Transporter 1 (MCT1; SLC16A1). Journal of medicinal chemistry 66 (1) (2022)
Sachin Puri, Katja Stefan, Sharuk L Khan, Jens Pahnke, Sven Marcel Stefan, Kapil Juvale
Indole Derivatives as New Structural Class of Potent and Antiproliferative Inhibitors of Monocarboxylate Transporter 1 (MCT1; SLC16A1). Journal of medicinal chemistry 66 (1) (2022)
Sven Marcel Stefan, Patric Jan Jansson, Jens Pahnke, Vigneshwaran Namasivayam
A curated binary pattern multitarget dataset of focused ATP-binding cassette transporter inhibitors. Scientific data 9 (1) (2022)
Jingyun Wu, Luisa Möhle, Thomas Brüning, Iván Eiriz, Muhammad Rafehi, Katja Stefan, Sven Marcel Stefan, Jens Pahnke
A Novel Huntington's Disease Assessment Platform to Support Future Drug Discovery and Development. International journal of molecular sciences 23 (23) (2022)
Sachin Puri, Katja Stefan, Sharuk L Khan, Jens Pahnke, Sven Marcel Stefan, Kapil Juvale
Indole Derivatives as New Structural Class of Potent and Antiproliferative Inhibitors of Monocarboxylate Transporter 1 (MCT1; SLC16A1). Journal of medicinal chemistry 66 (1) (2022)
Vigneshwaran Namasivayam, Katja Silbermann, Michael Wiese, Jens Pahnke, Sven Marcel Stefan
C@PA: Computer-Aided Pattern Analysis to Predict Multitarget ABC Transporter Inhibitors. Journal of medicinal chemistry 64 (6) (2021)
Sven Marcel Stefan, Patric J Jansson, Danuta S Kalinowski, Rukhsana Anjum, Mahendiran Dharmasivam, Des R Richardson
The growing evidence for targeting P-glycoprotein in lysosomes to overcome resistance. Future medicinal chemistry 12 (6) (2020)
Sven Marcel Stefan
Multi-target ABC transporter modulators: what next and where to go? Future medicinal chemistry 11 (18) (2019)
Michael Wiese, Sven Marcel Stefan
The A-B-C of small-molecule ABC transport protein modulators: From inhibition to activation-a case study of multidrug resistance-associated protein 1 (ABCC1). Medicinal research reviews 39 (6) (2019)
Sven Marcel Stefan, Michael Wiese
Small-molecule inhibitors of multidrug resistance-associated protein 1 and related processes: A historic approach and recent advances. Medicinal research reviews 39 (1) (2018)

Sven Marcel Stefan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sven Marcel Stefan